Company news

Zenabis Global Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Zenabis Provides Cannabis 2.0 Product and Strategy Update

February 19, 2020

Zenabis Provides Operations Update and Highlights for December 2019

February 5, 2020

Zenabis Provides Operations Update and Highlights for November 2019

January 16, 2020

Zenabis Announces Partial Conversion of Secured Convertible Notes

January 16, 2020

Zenabis Announces Appointment of New Chief Financial Officer

January 2, 2020

Zenabis Announces Receipt of License Amendment of Zenabis Langley for an Additional 69% Increase in Total Annual Capacity

December 16, 2019

Zenabis Global Inc. Announces Transition of Chief Executive Officer with Appointment of Kevin Coft

December 11, 2019

Zenabis Announces Details of Completed Over-Subscribed Rights Offering

December 9, 2019

Zenabis Provides Operations Update and Highlights for October 2019

December 4, 2019

Zenabis Announces Completion of Over-Subscribed Rights Offering

November 28, 2019

Zenabis Announces New Appointment to Board of Directors

November 21, 2019

Zenabis Global Announces Third Quarter 2019 Financial Results

November 14, 2019

Zenabis to Host Investor Conference Call on October 29, 2019 to discuss Rights Offering

October 28, 2019

Zenabis Announces Rights Offering to Raise Up To $20.8 Million

October 24, 2019

Zenabis Announces Cultivation Agreement with Tantalus Labs

October 22, 2019

Zenabis Provides Operations Update for September 2019

October 21, 2019

Zenabis Enters into Agreement with PAX Labs to become a PAX Era Brand Partner

September 30, 2019

Zenabis Announces Receipt of Final License Amendment for Zenabis Atholville

September 23, 2019

Zenabis Provides Operations Update for August 2019

September 18, 2019

Zenabis to Supply Recreational Cannabis to Ontario Cannabis Stores

September 10, 2019

Zenabis Provides Operations Update for July 2019

August 28, 2019

Zenabis Signs Agreement for Entrance into Cannabis-Infused Beverage Market

August 26, 2019

Zenabis Announces $25 Million in Additional Debt Financing and Extension and Partial Conversion of Secured Convertible Notes

August 21, 2019

Zenabis Global Announces Second Quarter 2019 Financial Results

August 14, 2019

Zenabis Receives Cultivation License for Zenabis Langley, Increasing Total Licensed Annual Cultivation Capacity by More Than 30%

August 6, 2019

Zenabis Announces Increase in Licensed Capacity by More Than 40% and Substantial Completion of Zenabis Atholville

July 29, 2019

Zenabis Outperforms Design Capacity by 41% in June

July 24, 2019

Zenabis Arranges $10 Million Non-Dilutive Financing via Supply Agreement with Starseed Medicinal Inc.

July 22, 2019

Zenabis Closes $30 Million Non-Dilutive Financing via Supply Agreement with Tilray®

July 11, 2019

Zenabis Submits Site Evidence Package to Health Canada for Langley Facility

July 9, 2019

Zenabis Announces Closing of Previously Announced Amendment and Extension of $25 Million Credit Facility

July 8, 2019

Zenabis Arranges $30 Million Non-Dilutive Financing via Supply Agreement with Tilray®

July 2, 2019

Zenabis Announces Amendment and Extension of $25 Million Credit Facility

July 2, 2019

Zenabis Outperforms Design Capacity by 35% in May and Announces 70% Increase in Licensed Annual Cultivation Capacity

June 24, 2019

Zenabis Announces Receipt of Industrial Hemp Production License and Other Licensing Updates

June 3, 2019

Zenabis Global Announces First Quarter 2019 Financial Results

May 30, 2019

Zenabis Announces Graduation to the Toronto Stock Exchange

May 24, 2019

Zenabis Provides Operational Update for April 2019

May 21, 2019

Zenabis Announces New Appointment to Board of Directors

May 21, 2019

Zenabis Announces Increase in Licensed Capacity by More Than 30% and Provides Date for Next Operational Update

May 13, 2019

Zenabis Announces Grant of Stock Options

May 2, 2019

Zenabis Provides Operational and Corporate Updates and Files Sun Pharm Investments Ltd. Year End Financial Statements on SEDAR

April 29, 2019

Zenabis Partners with Farmako to Supply Mass Produced CBD Isolate in Canada and Medical Cannabis to Germany

April 29, 2019

Zenabis Expands Recreational Cannabis Product Offerings in Key Domestic Markets

April 23, 2019

Zenabis Conditionally Approved to Graduate to the Toronto Stock Exchange

April 22, 2019

Zenabis Closes Previously Announced Public Offering and Exercise of Over-allotment Option

April 17, 2019

Zenabis Announces Appointment of New Chief Financial Officer and Files Final Base Short Form Prospectus

April 10, 2019

Zenabis Global Inc. Announces Resignation of Donald Fairholm from Board of Directors

April 1, 2019

Zenabis Completes $15 million First Tranche of $75 million Convertible Debenture Financing

March 27, 2019

Zenabis Enters European Pharmaceutical Cannabis Market

March 21, 2019

← Newer news releases · Older news releases →

Decks